title: Management of hyponatremia.
authors.forename: Jennifer Ji Young
authors.initials: JJ
authors.lastname: Lee
authors.forename: Kajiru
authors.initials: K
authors.lastname: Kilonzo
authors.forename: Amy
authors.initials: A
authors.lastname: Nistico
authors.forename: Karen
authors.initials: K
authors.lastname: Yeates
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists; D001549:Benzamides / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000175:diagnosis* / Q000188:drug therapy*; D020896:Hypovolemia / Q000175:diagnosis / Q000628:therapy; D007177:Inappropriate ADH Syndrome / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D009025:Morpholines / Q000627:therapeutic use; D011379:Prognosis; D011758:Pyrroles / Q000627:therapeutic use; D017483:Receptors, Vasopressin / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D013141:Spiro Compounds / Q000627:therapeutic use; D000077602:Tolvaptan; D016896:Treatment Outcome; D001569:Benzodiazepines
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001549:Benzamides; D001552:Benzazepines; D009025:Morpholines; D011758:Pyrroles; D017483:Receptors, Vasopressin; D013141:Spiro Compounds; D000077602:Tolvaptan; C106389:conivaptan; C409452:lixivaptan; D001569:Benzodiazepines; C103281:satavaptan